Kenyatta University Teaching, Referral & Research Hospital

20/02/2026

Having specialised childhood cancer treatment at KUTRRH is a game‑changer. With most childhood cancers being treatable, this brings life‑saving care closer to the children who need it most.

19/02/2026

The Pediatric Surgery Clinic offers comprehensive surgical evaluation and management for infants, children, and adolescents.

🗓 Tuesdays
⏰ 8:00 a.m. – 1:00 p.m.

19/02/2026

When Esther welcomed her daughter Ella into the world, she imagined raising a lively, healthy child who would grow and hit her milestones with ease. And for the first few months, that dream seemed to be coming true. Ella fed well, responded to her surroundings, and developed just as expected.

But at only five months old, everything changed.
https://www.kutrrh.go.ke/service/early-occupational-therapy/

18/02/2026

17/02/2026

https://www.youtube.com/watch?v=-zkXUJKX-uc

“Oh, I like that question. Children have a much, much better survival rate when it comes to cancers. Let people know that there are treatment options for ped...

16/02/2026

Early Results Revealed: KUTRRH Showcases Progress in Kenya’s Oesophageal Cancer Survival Project
https://bit.ly/3MNu6It

15/02/2026

International Childhood Cancer Day is held on the 15 February each year. Childhood cancer affects individuals and families all year round, but the day itself provides a moment for us to raise awareness and develop a deeper understanding of the unique issues and challenges faced by those whose lives are touched by childhood cancer.

14/02/2026

12/02/2026

Have you ever wondered who is an ideal candidate for Lutetium‑177 PSMA therapy?
This advanced therapy is recommended for:

• Patients with advanced or metastatic prostate cancer
• Individuals whose cancer has progressed despite hormone therapy
• Patients currently on chemotherapy or those who cannot tolerate chemotherapy
Before treatment, each patient undergoes a PSMA PET scan at KUTRRH to confirm eligibility. This ensures the therapy is provided only to those most likely to benefit—reflecting the hospital’s commitment to personalised, evidence based care.
Learn more:https://shorturl.at/6LYaa

11/02/2026

Today, the KUTRRH fraternity, together with family and friends, gathered to honour and celebrate the life of Mr. Andrew Nyaga Njagi, Deputy Catering Manager in the Directorate of Administration and Corporate Services. Tributes from colleagues, leadership, and loved ones reflected a humble, dedicated, and dependable man whose service left a lasting impact. The Catering Team remembered him fondly, sharing, “While maintaining professionalism, you supported us through everything… you were our counsel and guide.” Dr. Tabby Mungai (Director, Human Resource & Development) and Dr. John Nyambega (Director, Administration & Corporate Services) highlighted his professionalism, commitment to people, and devotion to both his work and family, while CEO Dr. Zeinab Gura described him as a patient, considerate, and caring professional whose contribution to KUTRRH will not be forgotten.

Family members remembered him as a good man—loving, responsible, and devoted to his home. Andrew was more than a colleague; he was family. We continue to keep his loved ones and the entire KUTRRH fraternity in our thoughts and prayers. May his soul rest in eternal peace.

11/02/2026

What Makes Lutetium 177 PSMA Therapy a Breakthrough Treatment for Prostate Cancer?
Lutetium 177 PSMA therapy is a highly precise form of targeted radiation treatment. It works by combining:
• Lutetium 177, a therapeutic radioactive isotope
• PSMA targeting molecules, which seek out prostate cancer cells
This combination allows radiation to be delivered directly to cancer cells, sparing most surrounding healthy tissue for the prostate.

11/02/2026

Kenyatta University Teaching, Referral & Research Hospital (KUTRRH) has achieved a remarkable medical breakthrough—becoming the first public hospital in East Africa to offer Lutetium 177 PSMA targeted radiation therapy, an innovative treatment giving new hope to patients with advanced prostate cancer.Learn more:https://shorturl.at/6LYaa